CEO's get hired and replaced , he was there when they started in july 2013 and was good for PR and raising capital and as someone mentioned "the board needs people with a commercial mindset"
"The Board of OncoSil looks forward to Mr Kenny adding value in his new role through his extensive commercialisation and clinical research experience. Mr Kenny will be taking the leadership position in driving the development of the OncoSilTM device with global regulatory authorities. FDA and EMA approval for pancreatic cancer is the core focus of OncoSilTM"
CEO's get hired and replaced , he was there when they started in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.050(4.42%) |
Mkt cap ! $20.33M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.15 | $1.08 | $45.62K | 40.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 718 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 2361 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |